Incyte Corporation announced on October 15, 2023, that the U.S. Food and Drug Administration (FDA) has awarded the company Breakthrough Therapy designation for its experimental drug,...
Incyte Corporation announced on October 22, 2023, that the U.S. Food and Drug Administration (FDA) has awarded Breakthrough Therapy designation to its experimental drug, INCA033989. This...